Showing 49–60 of 140 results

Show sidebar
Show 9 12 18 24
Compare

Lupkynis (voclosporin)

£13,683.30 – £13,983.30
Lupkynis (voclosporin) is a medication used with other medicines to treat adults with active lupus nephritis (LN).
Add to wishlist
Select options
Quick view
Compare

Lynparza (olaparib)

£4,329.56
Lynparza (olaparib) is a medication used for the treatment of ovarian, fallopian tube, primary peritoneal cancer, prostate cancer, prostate cancer and breast cancer.
Add to wishlist
Select options
Quick view
Compare

Mavenclad (cladribine)

£1,353.62 – £7,800.00
Mavenclad (cladribine) is a medication used for the treatment of relapsing forms of multiple sclerosis (MS). For this product the estimated delivery time is usually between 5 and 10 working days.
Add to wishlist
Select options
Quick view
Compare

Mayzent (Siponimod)

Mayzent (siponimod) is a medication used for the treatment of multiple sclerosis (MS).
Add to wishlist
Price available on request
Quick view
Compare

Mylan / Viramune (nevirapine)

£209.03 – £231.05
Viramune (nevirapine) is a prescription medicine for combination antiretroviral treatment of HIV-1 infection 1. Viramune (nevirapine) is widely approved, including by the FDA in the USA, the EMA in the EU, and the MHRA in the UK.
Add to wishlist
Select options
Quick view
Compare

Nexletol (bempedoic acid)

£320.00
Nexletol (bempedoic acid) is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels)
Add to wishlist
Add to cart
Quick view
Compare

Ninlaro (ixazomib)

£5,150.00
Ninlaro (ixazomib) is a medication used for the treatment of multiple myeloma.
Add to wishlist
Select options
Quick view
Compare

Ocaliva (obeticholic acid)

£1,600.00 – £3,800.00
Ocaliva (obeticholic acid) is a medication for the treatment of primary biliary cholangitis (PBC).
Add to wishlist
Select options
Quick view
Compare

Ocrevus (ocrelizumab)

£5,016.33
Ocrevus (ocrelizumab) is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis (MS). It is the first approved treatment for the primary progressive form of MS.
Add to wishlist
Select options
Quick view
Compare

Odomzo (sonidegib)

£4,542.90
Odomzo (sonidegib) is a medication for the treatment of locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation therapy.
Add to wishlist
Select options
Quick view
Compare

Olumiant (baricitinib)

£720.00 – £2,500.00
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis. On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Add to wishlist
Select options
Quick view
Compare

Olumiant (baricitinib)

£900.00 – £3,200.00
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis. On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Add to wishlist
Select options
Quick view